EUVIMEDEUVIMED entdecken
Crossref

Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids

Yan Mengmeng iD, Wen Chao iD, Yan Kuan iD, Zhu Tianshuo, Ma Congcong, Wang Zhanliang

Drug Testing and Analysis · 13.11.2026

DOI: 10.1002/dta.70179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 13.11.2026. Verfasst von Yan Mengmeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anti-Doping Laboratory, Beijing Sport University, Beijing, China. Die Arbeit nennt 21 Literaturangaben. Gefördert von: General Administration of Sport of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS) is used as a confirmation procedure for detecting the administration of synthetic forms of endogenous anabolic androgenic steroids (EAAS) by comparing the carbon isotope ratios ( δ 13 C) of target compounds (TCs) with those of endogenous reference compounds (ERCs). In recent years, some samples have been found to still contain interfering matrix components in different TC/ERC fractions after HPLC purification, which can rapidly deactivate the GC/C/IRMS reactor. 1‐(2,6‐Dichlorophenyl)indolin‐2‐one (1‐(DCP)I) has been identified as a major contributor to reactor deactivation. Subsequent studies suggested that 1‐(DCP)I was associated with diclofenac (DCF), a major metabolite formed following DCF sodium administration. DCF can persist in target fractions even after purification by one‐ or two‐dimensional semipreparative liquid chromatography coupled with fraction collection. During subsequent GC/C/IRMS analysis, residual chlorinated substances in purified fractions may contribute to oxidation reactor deactivation, thereby interfering with the determination of analyte ‘s δ 13 C values. Optimization of the backflush time in the GC/C/IRMS system can effectively minimize the influence of these chlorine‐containing substances on analysis.

Schlagwörter

Stichwörter der Autor:innen

GC/C/IRMSdiclofenacdoping controlreactor deactivation

Autor:innen und Institutionen

  • Beijing Anti-Doping Laboratory, Beijing Sport University, Beijing, China.

ORCID-Profile: Yan Mengmeng, Wen Chao, Yan Kuan

Förderung

  • General Administration of Sport of China

Zitieren

APA

Mengmeng, Y., Chao, W., Kuan, Y., Tianshuo, Z., Congcong, M., & Zhanliang, W. (2026). Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids. Drug Testing and Analysis. https://doi.org/10.1002/dta.70179

Vancouver

Mengmeng Y, Chao W, Kuan Y, Tianshuo Z, Congcong M, Zhanliang W. Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids. Drug Testing and Analysis. 2026. doi:10.1002/dta.70179

BibTeX
@article{Mengmeng2026,
  author = {Mengmeng, Yan and Chao, Wen and Kuan, Yan and Tianshuo, Zhu and Congcong, Ma and Zhanliang, Wang},
  title = {Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ 13 C Values of Steroids},
  journal = {Drug Testing and Analysis},
  year = {2026},
  doi = {10.1002/dta.70179}
}
Kostenlos starten →